Literature DB >> 139882

Drug induced interstitial nephritis, hepatitis and exfoliative dermatitis.

R A McMenamin, L M Davies, P W Craswell.   

Abstract

Acute interstitial nephritis associated with hepatitis, exfoliative dermatitis, fever and eosinophilia is uncommon. The syndrome has been described previously in association with phenindione administration, leptospirosis and heavy metal poisoning. Four cases are described, two of which were due to phenindione sensitivity. The other two patients had been exposed to a number of toxins including allopurinol, frusemide, chlorothiazide and methyldopa so that the exact aetiological agent is unclear. Interstitial nephritis should be considered as a cause of acute renal failure in patients with other features of drug hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 139882     DOI: 10.1111/j.1445-5994.1976.tb04001.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  7 in total

1.  Granulomatous interstitial nephritis associated with allopurinol therapy.

Authors:  P Magner; J Sweet; R A Bear
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

2.  Allopurinol, erythema multiforme, and renal insufficiency.

Authors:  A Kumar; N Edward; M I White; P W Johnston; G R Catto
Journal:  BMJ       Date:  1996-01-20

3.  Interstitial nephritis in a case of phenylbutazone hypersensitivity.

Authors:  G I Russell; R F Bing; J Walls; N M Pettigrew
Journal:  Br Med J       Date:  1978-05-20

4.  Treatment of acute interstitial nephritis.

Authors:  H G Laberke
Journal:  Klin Wochenschr       Date:  1980-05-16

5.  [Toxic nephropathies (author's transl)].

Authors:  E Heidbreder; A Heidland
Journal:  Klin Wochenschr       Date:  1980-02-01

Review 6.  Tubulointerstitial nephritis.

Authors:  C L Jones; A A Eddy
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

Review 7.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.